KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Synopsys (SNPS) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Synopsys (SNPS) over the last 17 years, with Q4 2025 value amounting to $3.0 billion.

  • Synopsys' Cash & Equivalents fell 2689.71% to $3.0 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $3.0 billion, marking a year-over-year decrease of 2689.71%. This contributed to the annual value of $3.0 billion for FY2025, which is 2689.71% down from last year.
  • As of Q4 2025, Synopsys' Cash & Equivalents stood at $3.0 billion, which was down 2689.71% from $2.6 billion recorded in Q3 2025.
  • In the past 5 years, Synopsys' Cash & Equivalents registered a high of $14.3 billion during Q2 2025, and its lowest value of $1.0 billion during Q1 2021.
  • Over the past 5 years, Synopsys' median Cash & Equivalents value was $1.5 billion (recorded in 2023), while the average stood at $2.4 billion.
  • Over the last 5 years, Synopsys' Cash & Equivalents had its largest YoY gain of 84764.29% in 2025, and its largest YoY loss of 2689.71% in 2025.
  • Quarter analysis of 5 years shows Synopsys' Cash & Equivalents stood at $1.4 billion in 2021, then dropped by 1.07% to $1.4 billion in 2022, then rose by 11.67% to $1.6 billion in 2023, then skyrocketed by 155.45% to $4.1 billion in 2024, then fell by 26.9% to $3.0 billion in 2025.
  • Its Cash & Equivalents stands at $3.0 billion for Q4 2025, versus $2.6 billion for Q3 2025 and $14.3 billion for Q2 2025.